Tuesday, 17 November 2026 Every SEC filing alert, by company
ALFA USA Filings Every alert, straight from SEC EDGAR
News
Financial Results · Q1 2026

Pluri Q1 2026 Results: Net Loss of $10.4M, Loss Widens

Pluri Inc. reported a significant increase in net loss to $15.39 million for the quarter ended September 30, 2026, primarily driven by a $10.9 million charge for acquired in-process research and development related to the Fishway Transaction. Despite the loss, revenues grew to $759,000 compared to $316,000 in the prior year, and the company successfully raised capital through share issuances and a SAFE agreement.

Q1 2026 at a glance · $ million
MetricQ1 2026Q1 2025
Revenue0.80.3
Gross profit0.40.1
Profit before tax-15.4-6.1
Net income-10.4-5.8
EPS (diluted, $ a share)$-0.85$-0.65

A dash means the filing did not report that period. Growth is not shown when either period was a loss. Figures from the filing's XBRL data.

Growth and margins
Revenue, year on year+140.2%
Gross margin55.3%
Source

10-Q filed with the SEC, NASDAQ: PLUR. Figures from the filing's XBRL data; summary written with AI assistance from the filing.

Read the filing ↗

Pluri Inc.: key numbers

Share price
$1.04Close, Nov 16
Market cap
$12.8M
Shares outstanding
12.34MLatest SEC cover page
Sector
Life Sciences
Industry
Biological Products, (No Diagnostic Substances)SIC 2836

Today's reference numbers, updated daily. Not a valuation or a recommendation.

More from Pluri Inc.

All →
8:31 AM ET 8-K
Partnership

Pluri Partnership with ZEO ScientifiX, Inc.

Pluri Inc. entered into a partnership agreement with ZEO ScientifiX to grant ZEO an exclusive license to manufacture and commercialize Pluri's regenerative medicine portfolio in the United States. In exchange, Pluri will receive a 50% equity stake in ZEO and the right to designate four out of seven board members, while ZEO will receive approximately 9% of Pluri's outstanding common shares.

Counterparty
ZEO ScientifiX, Inc.
6:06 AM ET Form 4
Insider Buying

Pluri Insider Alexandre Weinstein Manieu Buys $1.25M of Stock

Alexandre Weinstein Manieu bought 833,334 shares of Pluri Inc. at $1.50 a share, worth $1.25M in total on Oct 23, 2026. Shares held after the trade: 2,083,334 (+66.7%).

Value
$1.25M
Shares
833,334
Price
$1.50
Holding change
+66.7%
Trade date
Oct 23, 2026
4:00 PM ET 8-K
Capital Raise

Pluri Capital Raise of $1.25M

Pluri Inc. entered into a Securities Purchase Agreement with its largest shareholder, Chutzpah Holdings LP, to issue 833,334 common shares and warrants to purchase an additional 833,334 shares. The $1.25 million aggregate purchase price was satisfied by an advance payment previously received by the company in June 2026. The shares were priced at $1.50 per share, with the warrants carrying an exercise price of $1.65.

Value
$1.25M
Counterparty
Chutzpah Holdings LP

Get Alerts

Get ALFA Finder alerts first

Real-time SEC filing alerts for US stocks are launching soon. Leave your details and we'll tell you the moment they go live.